Search

Author/Creator Thomas, Sheeba

1. Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenström's macroglobulinemia. Issue 4 (21st March 2019)

Authors:
Chaudhry, Maria; Steiner, Raphael; Claussen, Catherine; Patel, Krina; Lee, Hans; Weber, Donna; Thomas, Sheeba; Feng, Chun; Amini, Behrang; Orlowski, Robert; Feng, Lei; Manasanch, Elisabet E.
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 4(2019)
Page Start:
964
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes. Issue 2 (28th January 2019)

Authors:
Hu, Bei; Thall, Peter; Milton, Denái R; Sasaki, Koji; Bashir, Qaiser; Shah, Nina; Patel, Krina; Popat, Uday; Hosing, Chitra; Nieto, Yago; Lin, Pei; Delgado, Ruby; Jorgensen, Jeffrey; Manasanch, Elisabet; Weber, Donna; Thomas, Sheeba; Orlowski, Robert Z.; Champlin, Richard; Qazilbash, Muzaffar H.
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 2(2019)
Page Start:
442
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗